Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 681 clinical trials
Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 Vaccine

COVID-19 is a novel coronavirus infection caused by respiratory droplets and contact transmission. With the spread of the epidemic, it has become a serious threat to global public health. China

Accepts healthy volunteers
  • 0 views
  • 25 May, 2022
Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19

The purpose of this study is to learn how to better detect infection and understand how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes lung disease and is spread. The novel

Accepts healthy volunteers
  • 0 views
  • 30 Jun, 2022
  • 4 locations
Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients

(base therapy: the actual proposed therapy of moderate SARS-CoV-2 infected patients according to "Hungarian Coronavirus Handbook", including antiviral and immunmodulant therapy and reconvalescent plasma

  • 6 views
  • 03 Oct, 2021
  • 4 locations
A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants

This is an open-label study to evaluate the safety, reactogenicity, and immunogenicity of mRNA-1273 Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2) vaccine in adults with a kidney or

Accepts healthy volunteers
  • 0 views
  • 14 Apr, 2022
  • 1 location
A Phase 2b Multi-Center Randomized Double-Blind Placebo-Controlled Study Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)

hospitalized patients with severe or critical Coronavirus Disease 2019 (COVID-19) with associated acute respiratory distress syndrome (ARDS). Patients will be followed for efficacy and safety for 6 months. The

  • 2 views
  • 29 Aug, 2021
  • 1 location
Study of COVID-19 Outbreak in Hospital Departments of Bamako Mali

The new coronavirus known as SARS-Cov-2 (severe acute respiratory syndrome -coronavirus 2) was first reported in December 2019 and rapidly became a public health emergency. The COVID-19 pandemic

  • 0 views
  • 04 Oct, 2021
Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults

This study evaluates an investigational vaccine that is designed to protect humans against infection with SARS-CoV-2, the novel coronavirus causing COVID-19 disease. The investigational vaccine

  • 0 views
  • 18 Jul, 2021
  • 2 locations
Comparative Genetic and Immune Response Analysis of Different COVID-19 Vaccine Candidates Using Multi-OMICS Approach (COVID 19-VAC)

Reaction of the immune system and the body to a Coronavirus-19 (COVID-19) vaccination is so different and ultimately unpredictable has not yet been clarified. It is also not yet known why people

Accepts healthy volunteers
  • 0 views
  • 25 May, 2022
  • 1 location
Evaluate the Efficacy and Safety of TF0023 in Treatments for COVID-19 in Hospitalized Adults

-19 in Hospitalized Adults, relieving of the signs and symptoms of acute respiratory distress syndrome (ARDS) and pneumonia caused by coronavirus disease 2019 (COVID-19).

  • 0 views
  • 05 Jun, 2022
  • 1 location
Efficacy of Home Inspiratory Muscle Training in Post-covid-19 Patients: a Randomized Clinical Trial

INTRODUCTION: Coronavirus 2019 disease (COVID-19), caused by the Severe Acute Respiratory Syndrome (SRAG) of coronavirus 2 (SARS-CoV-2) surpassed the global number of 119,603,761 cases, with

  • 0 views
  • 20 Oct, 2021
  • 2 locations